Seoul Pharma Co., Ltd 018680.KQ Stock
Seoul Pharma Co., Ltd Price Chart
Seoul Pharma Co., Ltd 018680.KQ Financial and Trading Overview
Seoul Pharma Co., Ltd stock price | 3325 KRW |
Previous Close | 4325 KRW |
Open | 4345 KRW |
Bid | 4285 KRW x 0 |
Ask | 4760 KRW x 0 |
Day's Range | 4315 - 4380 KRW |
52 Week Range | 3700 - 6850 KRW |
Volume | 15.16K KRW |
Avg. Volume | 15.52K KRW |
Market Cap | 36.74B KRW |
Beta (5Y Monthly) | 0.376771 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 KRW |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
018680.KQ Valuation Measures
Enterprise Value | 52.39B KRW |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.8690899 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 1.239 |
Enterprise Value/EBITDA | N/A |
Trading Information
Seoul Pharma Co., Ltd Stock Price History
Beta (5Y Monthly) | 0.376771 |
52-Week Change | -14.69% |
S&P500 52-Week Change | 20.43% |
52 Week High | 6850 KRW |
52 Week Low | 3700 KRW |
50-Day Moving Average | 4354 KRW |
200-Day Moving Average | 4621.43 KRW |
018680.KQ Share Statistics
Avg. Volume (3 month) | 15.52K KRW |
Avg. Daily Volume (10-Days) | 11.78K KRW |
Shares Outstanding | 8.49M |
Float | 539.72K |
Short Ratio | N/A |
% Held by Insiders | 0% |
% Held by Institutions | 32.52% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | N/A |
Trailing Annual Dividend Yield | N/A |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2011 |
Most Recent Quarter (mrq) | September 30, 2013 |
Next Fiscal Year End | December 31, 2012 |
Profitability
Profit Margin | 2.49% |
Operating Margin (ttm) | 3.74% |
Gross Margin | 51.32% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | N/A |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | 42.28B KRW |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | -3.20% |
Gross Profit (ttm) | 24.8B KRW |
EBITDA | N/A |
Net Income Avi to Common (ttm) | 1.05B KRW |
Diluted EPS (ttm) | N/A |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 4.44B KRW |
Total Cash Per Share (mrq) | 663.45 KRW |
Total Debt (mrq) | 27.94B KRW |
Total Debt/Equity (mrq) | 89.58 KRW |
Current Ratio (mrq) | 1.238 |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | 3.35B KRW |
Levered Free Cash Flow (ttm) | N/A |
Profile of Seoul Pharma Co., Ltd
Country | South Korea |
State | N/A |
City | Seoul |
Address | 21, Banpo-daero |
ZIP | 06710 |
Phone | 82 2 3470 2300 |
Website | https://www.seoulpharma.com |
Industry | |
Sector(s) | |
Full Time Employees | 230 |
Seoul Pharma Co., Ltd manufactures and distributes pharmaceutical products in South Korea and internationally. It provides Orally Disintegrating Film (ODF), a thin film that provides an alternative to orally disintegrating tablets with modifications. The company offers ODF products for therapeutic areas, including urology, neurology, nutrition, endocrinology, and OB/GY. Its products include VULTEUM and VULTIS for erectile dysfunction; ARTPEZIL for Alzheimer' disease; OBCARE to treat overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency; and CH.V for collagen, hyaluronic acid, and vitamin C, as well as products for schizophrenia, vitamin B, and fatigue and immunity. The company was founded in 1976 and is headquartered in Seoul, South Korea.
Q&A For Seoul Pharma Co., Ltd Stock
What is a current 018680.KQ stock price?
Seoul Pharma Co., Ltd 018680.KQ stock price today per share is 3325 KRW.
How to purchase Seoul Pharma Co., Ltd stock?
You can buy 018680.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Seoul Pharma Co., Ltd?
The stock symbol or ticker of Seoul Pharma Co., Ltd is 018680.KQ.
How many shares does Seoul Pharma Co., Ltd have in circulation?
The max supply of Seoul Pharma Co., Ltd shares is 11.66M.
What is Seoul Pharma Co., Ltd Price to Earnings Ratio (PE Ratio)?
Seoul Pharma Co., Ltd PE Ratio is now.
What was Seoul Pharma Co., Ltd earnings per share over the trailing 12 months (TTM)?
Seoul Pharma Co., Ltd EPS is 0 KRW over the trailing 12 months.